Director/PDMR Shareholding

Intl. Biotechnology Trust PLC
17 December 2024
 

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Kate Cornish-Bowden

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director

b)

 

Initial notification/amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

International Biotechnology Trust plc

b)

 

LEI

 

213800N1QUJ744P76D11

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 25 pence each

 

 

ISIN: GB0004559349

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£7.1264

 

1,500

 

 

 

 

d)

 

Aggregated information

 

-    Aggregated volume

 

-    Price

 

 

 

 

 

 

 

 

1,500

 

£10,689.60

e)

 

Date of the transaction

 

 

17 December 2024

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings